Definition
A hypertensive crisis is a severe elevation in blood pressure (BP) that poses an immediate risk of end‑organ damage. It is conventionally defined by a systolic BP ≥ 180 mm Hg and/or a diastolic BP ≥ 120 mm Hg. The condition is subdivided into:
- Hypertensive urgency – marked BP elevation without evidence of acute target‑organ injury.
- Hypertensive emergency – marked BP elevation accompanied by acute damage to the brain, heart, kidneys, eyes, or vasculature.
Epidemiology
Hypertensive crises occur in approximately 1–2 % of individuals with chronic hypertension annually. Hypertensive emergencies are less common than urgencies, representing roughly 0.1–0.5 % of hypertensive patients, and are more frequent among older adults and those with poorly controlled hypertension.
Etiology / Risk Factors
| Common precipitants | Typical contributors |
|---|---|
| Sudden discontinuation of antihypertensive agents (especially clonidine, β‑blockers) | Long‑standing uncontrolled hypertension |
| Acute renal failure or glomerulonephritis | Substance abuse (cocaine, amphetamines, excessive alcohol) |
| Preeclampsia/eclampsia in pregnancy | Sympathetic overactivity (pain, anxiety) |
| Drug interactions (e.g., non‑steroidal anti‑inflammatory drugs with ACE inhibitors) | Endocrine disorders (pheochromocytoma, hyperthyroidism, primary aldosteronism) |
| Vascular emergencies (aortic dissection, stroke) | Chronic non‑adherence to therapy |
Clinical Presentation
General – Severe headache, visual disturbances, nausea/vomiting, anxiety, altered mental status.
Urgency – Symptoms may be mild or absent; patients often report headache or dizziness.
Emergency – Rapidly progressive or profound neurologic deficits (e.g., seizures, focal weakness, confusion), acute chest pain, dyspnea, pulmonary edema, acute kidney injury (rise in creatinine), retinal hemorrhages or exudates, and signs of aortic dissection (tearing back pain).
Diagnostic Evaluation
- Confirmatory BP measurement – Use appropriately sized cuff; obtain at least two readings separated by a few minutes.
- Baseline laboratory studies – CBC, electrolytes, renal function (creatinine, BUN), fasting glucose, cardiac enzymes (troponin), urinalysis for hematuria/proteinuria.
- Electrocardiogram (ECG) – Assess for ischemia, left ventricular hypertrophy, or arrhythmias.
- Target‑organ assessment –
- Neuroimaging (CT/MRI) if neurologic symptoms.
- Chest X‑ray and bedside echocardiography for cardiac involvement.
- Fundoscopic examination for retinal changes.
- Urgent serum lactate or D‑dimer in suspected aortic dissection.
Management
General principles – Rapid but controlled lowering of BP to avoid hypoperfusion.
| Situation | Target BP reduction | Preferred agents |
|---|---|---|
| Hypertensive emergency (e.g., encephalopathy, aortic dissection, acute coronary syndrome) | Reduce MAP by ≤ 25 % within the first 8 h; aim for SBP ≈ 160 mm Hg, then gradually to ≤ 140 mm Hg over the next 24–48 h. | IV nicardipine, clevidipine, labetalol, fenoldopam, sodium nitroprusside (with caution), esmolol (aortic dissection). |
| Hypertensive urgency | Lower SBP to < 160 mm Hg over 24–48 h; no need for ICU monitoring. | Oral agents: clonidine, captopril, candesartan, amlodipine, valsartan, or combination therapy. |
Specific considerations
- Acute stroke – For intracerebral hemorrhage, reduce SBP to 140 mm Hg (Guidelines: AHA/ASA 2022). For ischemic stroke, aim for SBP < 185 mm Hg before thrombolysis.
- Preeclampsia/eclampsia – IV labetalol, hydralazine, or oral nifedipine; seizure prophylaxis with magnesium sulfate.
- Aortic dissection – Immediate β‑blockade (esmolol or labetalol) to target heart rate < 60 bpm, then add vasodilators if needed.
Monitoring
- Continuous arterial blood pressure (invasive or non‑invasive) in emergencies.
- Serial neurologic exams, urine output, electrolytes, and cardiac telemetry.
Prognosis
Prompt treatment of a hypertensive emergency markedly reduces mortality (estimated 10–15 % in untreated cases versus < 2 % when managed rapidly). Hypertensive urgencies, when appropriately addressed, have a favorable outcome, but they signal inadequate long‑term BP control and merit medication adjustment and close follow‑up.
Prevention
- Strict adherence to antihypertensive regimens.
- Regular BP monitoring and dose titration.
- Patient education on medication discontinuation risks.
- Lifestyle measures: low‑salt diet, weight control, regular aerobic activity, moderation of alcohol, and avoidance of illicit stimulants.
References
- 2022 American Heart Association/American College of Cardiology (AHA/ACC) Guideline for the Management of Hypertension. Hypertension.
- 2023 European Society of Cardiology (ESC) / European Society of Hypertension (ESH) Guidelines on Hypertension. European Heart Journal.
- 2022 AHA/ASA Scientific Statement on Management of Acute Stroke in Patients With Hypertension. Stroke.
- 2023 Society of Critical Care Medicine (SCCM) Consensus on Emergency Management of Hypertensive Crises. Critical Care Medicine.
This entry reflects current consensus up to 2024 and does not incorporate unpublished or anecdotal data.
